Subsequent overexpression of TIGAR in HNSCC cells eliminated the growth inhibitory effects of c-Met inhibitors, while also reportedly upregulating mesenchymal markers such as vimentin [63,64]. The gene discussed is MET; the disease is head and neck squamous cell carcinoma.